Breaking News Instant updates and real-time market news.

DDD

3D Systems

$10.59

-0.4 (-3.64%)

16:24
05/07/19
05/07
16:24
05/07/19
16:24

3D Systems reports Q1 EPS (9c), consensus (1c)

Reports Q1 revenue $152M, consensus $164.69M. "While we expected seasonality in our revenue this year from ordering patterns of enterprise customers, the first quarter was lower than anticipated as a result of shipment timing and additional on demand weakness," commented Vyomesh Joshi (VJ) chief executive officer, 3D Systems. "We are taking actions to improve performance for the balance of the year, including accelerating cost reductions." "With the breadth and strength of our portfolio, we continue to have significant market opportunities to expand our market share and are committed to executing our plans to drive long term profitable growth," concluded Joshi.

  • 07

    May

  • 08

    May

  • 21

    May

DDD 3D Systems
$10.59

-0.4 (-3.64%)

03/01/19
JPMS
03/01/19
NO CHANGE
Target $8
JPMS
Underweight
3D Systems price target lowered to $8 from $10 at JPMorgan
JPMorgan analyst Paul Coster lowered his price target for 3D Systems to $8 following the company's Q4 results and keeps an Underweight rating on the shares. Though the company looks for profitable growth in 2019, progress will be "heavily" backend-loaded, owing to slower enterprise sales in the seasonally weak Q1, and a continued delay in anticipated materials ramp, Coster tells investors in a research note. Further, while printer shipment growth continues to be strong, average selling prices are declining, adds the analyst.
04/01/19
JPMS
04/01/19
NO CHANGE
JPMS
Underweight
3D Systems, Stratasys struggling to defend market share, says JPMorgan
This year's Wohlers Report continues to depict a competitive 3D industry whose growth is increasingly fueled by end-parts manufacturing and functional prototyping, JPMorgan analyst Paul Coster tells investors in a research note. 3D Systems (DDD) and Stratasys (SSYS) are struggling to defend market share in a growing 3D production market, owing to stiffening competition from bigger companies that are entering the industrial system space, says the analyst. He keeps an Underweight rating on both names. Coster believes the "paucity of pure-play investable ideas continues to buoy valuation multiples beyond the level justified by actual growth prospects."
04/22/19
CHLM
04/22/19
INITIATION
Target $12
CHLM
Hold
3D Systems initiated with a Hold at Craig-Hallum
Craig-Hallum analyst Greg Palm started coverage of 3D Systems with a Hold rating and a $12 price target. The analyst likes the company's positioning in healthcare especially, but "erratic results" make this "a show me story."
04/30/19
PIPR
04/30/19
NO CHANGE
PIPR
3D printing demand trends improving into Q1 results, says Piper Jaffray
Piper Jaffray analyst Troy Jensen says his Q1 reseller survey indicates 3D printing demand was mostly in line with expectations for the March quarter. System demand down-ticked quarter-over-quarter, but was up "nicely" on a year-over-year basis, while material demand was modestly above plan and service bureau demand "bounced back sharply following a challenging Q4," Jensen tells investors in a research note. He believes underlying demand trends are improving for the 3D printing industry and anticipates accelerating growth as the industry moves through 2019 and beyond. Stratasys' (SSYS) new product introductions and production emphasis will see growth pick up in the second half of 2019, contends the analyst. And 3D Systems (DDD) should also benefit from production application demand improving and other new product launches, Jensen adds. He reiterates Overweight ratings on both stocks.

TODAY'S FREE FLY STORIES

SRE

Sempra Energy

$131.47

0.29 (0.22%)

05:55
05/22/19
05/22
05:55
05/22/19
05:55
Hot Stocks
Sempra Energy, Aramco Services sign HOA for Port Arthur LNG »

Sempra Energy and Saudi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

05:55
05/22/19
05/22
05:55
05/22/19
05:55
Conference/Events
Deutsche Bank to hold a conference »

10th Annual Asia…

AAT

American Assets Trust

$45.91

0.45 (0.99%)

, BRX

Brixmor

$18.26

0.3 (1.67%)

05:55
05/22/19
05/22
05:55
05/22/19
05:55
Conference/Events
Mizuho to hold company meetings at a conference »

Mizuho Company Meetings…

AAT

American Assets Trust

$45.91

0.45 (0.99%)

BRX

Brixmor

$18.26

0.3 (1.67%)

CBL

CBL & Associates

$1.10

0.005 (0.46%)

EPRT

Essential Properties Realty Trust

$21.15

0.44 (2.12%)

HF

HFF Inc.

$44.24

0.1 (0.23%)

JLL

Jones Lang LaSalle

$132.21

0.985 (0.75%)

MAC

Macerich

$41.53

0.9 (2.22%)

SPG

Simon Property

$172.82

2.35 (1.38%)

TCO

Taubman Centers

$49.90

0.945 (1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 04

    Jun

  • 04

    Jun

  • 07

    Jun

  • 11

    Jun

  • 11

    Jun

  • 30

    Jul

  • 26

    Aug

AVP

Avon Products

$3.20

0.06 (1.91%)

05:49
05/22/19
05/22
05:49
05/22/19
05:49
Periodicals
Natura to buy Avon in all-stock deal valued over $2B, FT reports »

Brazil's Natura…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$3.20

0.06 (1.91%)

05:45
05/22/19
05/22
05:45
05/22/19
05:45
Periodicals
Avon Products nearing sale to Brazil's Natura, WSJ reports »

Avon Products (AVP) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$169.62

1.26 (0.75%)

05:41
05/22/19
05/22
05:41
05/22/19
05:41
Hot Stocks
Amgen announces recommended public cash offer to the shareholders of Nuevolution »

Amgen announces a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

NVS

Novartis

$82.38

0.36 (0.44%)

05:38
05/22/19
05/22
05:38
05/22/19
05:38
Hot Stocks
Novartis: QVM149 phase II data shows improvements over current standard-of-care »

Novartis announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

HALO

Halozyme

$15.60

0.385 (2.53%)

05:25
05/22/19
05/22
05:25
05/22/19
05:25
Hot Stocks
Halozyme says argenx selected 2nd target under collaboration, license agreement »

Halozyme Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 31

    May

LM

Legg Mason

$36.89

1.21 (3.39%)

05:24
05/22/19
05/22
05:24
05/22/19
05:24
Upgrade
Legg Mason rating change  »

Legg Mason upgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SE

Sea Limited

$25.38

-0.42 (-1.63%)

05:16
05/22/19
05/22
05:16
05/22/19
05:16
Recommendations
Sea Limited analyst commentary at Piper Jaffray »

Sea Limited price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:13
05/22/19
05/22
05:13
05/22/19
05:13
Recommendations
Abiomed analyst commentary  »

Abiomed 20% selloff this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:10
05/22/19
05/22
05:10
05/22/19
05:10
Hot Stocks
Abiomed says FDA confirmed Impella RP heart pump is 'safe and effective' »

Abiomed yesterday …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:08
05/22/19
05/22
05:08
05/22/19
05:08
Hot Stocks
FDA says benefits of Impella RP system continue to outweigh risks »

The FDA told doctors in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

FLIR

Flir Systems

$49.66

0.65 (1.33%)

05:02
05/22/19
05/22
05:02
05/22/19
05:02
Upgrade
Flir Systems rating change  »

Flir Systems upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 27

    Jun

TMDI

Titan Medical

$2.70

0.2 (8.00%)

04:59
05/22/19
05/22
04:59
05/22/19
04:59
Initiation
Titan Medical initiated at Piper Jaffray »

Titan Medical initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRXC

TransEnterix

$1.27

-0.03 (-2.32%)

04:57
05/22/19
05/22
04:57
05/22/19
04:57
Initiation
TransEnterix initiated at Piper Jaffray »

TransEnterix initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
05/22/19
05/22
04:55
05/22/19
04:55
General news
Breaking General news story  »

Week of 5/17 MBA Mortgage…

PFG

Principal Financial

$55.31

0.41 (0.75%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Principal Financial Group participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 11

    Jun

  • 26

    Jul

STML

Stemline

$15.07

0.71 (4.94%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Stemline management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Credit Suisse U.S. strategist team to hold an analyst/industry conference call »

The U.S. Sector…

MED

Medifast

$146.66

1.35 (0.93%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Medifast management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 12

    Jun

EXTR

Extreme Networks

$6.15

0.11 (1.82%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
JPMorgan telecom/IT hardware analyst to hold an analyst/industry conference call »

Telecom & IT Hardware…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 28

    May

  • 30

    May

BANR

Banner Corp.

$53.76

-0.04 (-0.07%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Banner Corp. management to meet with Sandler ONeill »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

CHD

Church & Dwight

$73.99

-0.02 (-0.03%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Church & Dwight management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

MSM

MSC Industrial

$75.80

0.57 (0.76%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
MSC Industrial management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

  • 05

    Jun

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.